ABL Bio Inc. (KOSDAQ:298380)
South Korea
· Delayed Price · Currency is KRW 194,000
+2,900 (1.52%)
Feb 27, 2026, 3:30 PM KST
390.52% (1Y)
| Market Cap | 10.73T |
| Revenue (ttm) | 88.44B |
| Net Income (ttm) | -28.65B |
| Shares Out | 55.30M |
| EPS (ttm) | -575.68 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 611,025 |
| Average Volume | 1,118,876 |
| Open | 190,900 |
| Previous Close | 191,100 |
| Day's Range | 189,000 - 195,900 |
| 52-Week Range | 31,300 - 257,500 |
| Beta | 0.51 |
| RSI | 50.07 |
| Earnings Date | Feb 6, 2026 |